BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 33618763)

  • 1. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
    Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
    Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression.
    Wang X; Prager BC; Wu Q; Kim LJY; Gimple RC; Shi Y; Yang K; Morton AR; Zhou W; Zhu Z; Obara EAA; Miller TE; Song A; Lai S; Hubert CG; Jin X; Huang Z; Fang X; Dixit D; Tao W; Zhai K; Chen C; Dong Z; Zhang G; Dombrowski SM; Hamerlik P; Mack SC; Bao S; Rich JN
    Cell Stem Cell; 2018 Apr; 22(4):514-528.e5. PubMed ID: 29625067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance.
    Thorne AH; Meisen WH; Russell L; Yoo JY; Bolyard CM; Lathia JD; Rich J; Puduvalli VK; Mao H; Yu J; Caligiuri MA; Tridandapani S; Kaur B
    Mol Ther; 2014 Sep; 22(9):1678-87. PubMed ID: 24895995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
    Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
    Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 6. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
    Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
    Front Immunol; 2021; 12():637053. PubMed ID: 34108959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages.
    Yuan W; Zhang Q; Gu D; Lu C; Dixit D; Gimple RC; Gao Y; Gao J; Li D; Shan D; Hu L; Li L; Li Y; Ci S; You H; Yan L; Chen K; Zhao N; Xu C; Lan J; Liu D; Zhang J; Shi Z; Wu Q; Yang K; Zhao L; Qiu Z; Lv D; Gao W; Yang H; Lin F; Wang Q; Man J; Li C; Tao W; Agnihotri S; Qian X; Mack SC; Zhang N; You Y; Rich JN; Sun G; Wang X
    Clin Cancer Res; 2023 Sep; 29(18):3779-3792. PubMed ID: 37439870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling.
    Peng P; Zhu H; Liu D; Chen Z; Zhang X; Guo Z; Dong M; Wan L; Zhang P; Liu G; Zhang S; Dong F; Hu F; Cheng F; Huang S; Guo D; Zhang B; Yu X; Wan F
    Theranostics; 2022; 12(9):4221-4236. PubMed ID: 35673564
    [No Abstract]   [Full Text] [Related]  

  • 11. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
    Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
    Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
    van den Bossche WBL; Kleijn A; Teunissen CE; Voerman JSA; Teodosio C; Noske DP; van Dongen JJM; Dirven CMF; Lamfers MLM
    Neuro Oncol; 2018 Oct; 20(11):1494-1504. PubMed ID: 29796615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PNIPAAm-co-Jeffamine
    Heffernan JM; McNamara JB; Borwege S; Vernon BL; Sanai N; Mehta S; Sirianni RW
    Biomaterials; 2017 Oct; 143():149-158. PubMed ID: 28802102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling.
    Chen J; Liu G; Wang X; Hong H; Li T; Li L; Wang H; Xie J; Li B; Li T; Lu D; Zhang Y; Zhao H; Yao C; Wen K; Li T; Chen J; Wu S; He K; Zhang WN; Zhao J; Wang N; Han Q; Xia Q; Qi J; Chen J; Zhou T; Man J; Zhang XM; Li AL; Pan X
    Cell Stem Cell; 2022 Nov; 29(11):1531-1546.e7. PubMed ID: 36265493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis.
    Zhai Y; Li G; Li R; Chang Y; Feng Y; Wang D; Wu F; Zhang W
    Front Immunol; 2020; 11():581209. PubMed ID: 33133100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.
    Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY
    Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
    Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL
    Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413
    [No Abstract]   [Full Text] [Related]  

  • 19. Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells.
    Qiu Z; Zhao L; Shen JZ; Liang Z; Wu Q; Yang K; Min L; Gimple RC; Yang Q; Bhargava S; Jin C; Kim C; Hinz D; Dixit D; Bernatchez JA; Prager BC; Zhang G; Dong Z; Lv D; Wang X; Kim LJY; Zhu Z; Jones KA; Zheng Y; Wang X; Siqueira-Neto JL; Chavez L; Fu XD; Spruck C; Rich JN
    Cancer Discov; 2022 Feb; 12(2):502-521. PubMed ID: 34615656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages.
    Dong M; Zhang X; Peng P; Chen Z; Zhang Y; Wan L; Xiang W; Liu G; Guo Y; Xiao Q; Wang B; Guo D; Zhu M; Yu X; Wan F
    Cancer Lett; 2024 May; 590():216801. PubMed ID: 38479552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.